SCM
ICUI icon

Silvant Capital Management’s ICU Medical ICUI Stock Holding History

Silvant Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,865
Closed -$470K – 342
2019
Q2 		$470K Hold
1,865
– – 0.08% 119
2019
Q1 		$446K Hold
1,865
– – 0.08% 125
2018
Q4 		$428K Hold
1,865
– – 0.09% 118
2018
Q3 		$527K Hold
1,865
– – 0.07% 119
2018
Q2 		$548K Hold
1,865
– – 0.07% 112
2018
Q1 		$471K Buy
+1,865
New +$438K 0.06% 122

Other funds holding ICUI

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Silvant Capital Management's ICUI Position: Q3 2019 in Review

Silvant Capital Management sold out of ICU Medical (ICUI) in Q3 2019, closing a stake of 1,865 shares — an estimated $470K sold.

Silvant Capital Management first reported a position in ICUI in Q1 2018 and held it in 6 quarters. The position peaked at $548K in Q2 2018. 260 funds tracked by Wall St. Rank hold ICUI as of Q3 2019.

  • Silvant Capital Management reported no remaining ICU Medical position as of Q3 2019 after selling out during the quarter.
  • Silvant Capital Management sold 1,865 ICU Medical shares in Q3 2019, an estimated $470K.
  • Silvant Capital Management first reported a position in ICU Medical in Q1 2018 and held it in 6 quarters.
  • Silvant Capital Management's ICU Medical position peaked at $548K in Q2 2018.
  • 260 funds tracked by Wall St. Rank held ICU Medical as of Q3 2019.

Based on Silvant Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.